Quarterly Results of Symbiotec Pharmalab Ltd. Company (Figures in Rs crores)

	Jun 30, 2026	Mar 31, 2026	Jun 30, 2025
Net Sales / Income	210.84	213.08	204.26
Other Income	19.55	18.68	11.47
Net Profit/Loss	47.01	-15.69	44.51
Raw Material	96.12	90.44	77.40
Power And Fuel	0	0	0
Employee Expenses	35.22	35.31	33.92
Excise
Admin And Selling Expenses	0	0	0
Research And Devlopment Expenses	0	0	0
Expenses Capitalised	0	0	0
Other Expenses	37.99	38.40	30.60
Provisions Made	0	0	0
Interest	5.62	6.45	5.11
Gross Profit	73.17	61.16	68.71
Depreciation	10.15	11.31	9.30
Taxation	16.01	12.73	14.90
Extra Ordinary Item	0	-52.81	0
Prior Year Adjustments	0	0	0
Equity Capital	12.55	12.55	10.94
Equity Dividend Rate	0	0	0
Agg.Of Non-Prom. Shares (in lacs)	0	0	0
Agg.Of Non PromotoHolding (%)	0	0	0
EPS (in Rs.)	7.49	-2.50	8.14

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

More Information on Symbiotec Pharmalab Ltd.

Symbiotec Pharmalab Ltd. Tools

Bulk Deals›

Symbiotec Pharmalab Ltd. Company Details

Company Profile› Company History› Management Team› Capital Structure› Product Mix› Banker/Auditor/Registrar›

Company History

BSE Price History› NSE Price History›

Symbiotec Pharmalab Ltd. Key Financial Ratios

Ratios›

Symbiotec Pharmalab Ltd. Results

Quarterly Results› Annual Results›

Symbiotec Pharmalab Ltd. Financial Data

Audited Results› Cash Flow› Balance Sheet›

Symbiotec Pharmalab Ltd. Corporate Announcements

Board Meetings› Change of Name›